PMID- 40977229
OWN - NLM
STAT- Publisher
LR  - 20250922
IS  - 1879-0844 (Electronic)
IS  - 1388-9842 (Linking)
DP  - 2025 Sep 22
TI  - Deep phenotyping of heart failure with preserved ejection fraction through 
      multi-omics integration.
LID - 10.1002/ejhf.70041 [doi]
AB  - AIMS: Heart failure with preserved ejection fraction (HFpEF) has become the 
      predominant form of heart failure and a leading cause of global cardiovascular 
      morbidity and mortality. Due to its heterogeneous nature, HFpEF presents 
      substantial challenges in diagnosis and management. Given the limited treatment 
      options and lifestyle-associated comorbidities, early identification is crucial 
      for establishing effective preventive strategies. Here, we introduce and validate 
      a machine learning-based multi-omics approach that integrates clinical and 
      molecular data to detect and characterize HFpEF. METHODS AND RESULTS: A 
      supervised classifier was trained on a stratified subset of UK Biobank 
      participants (n = 401 917) to identify phenotypic profiles associated with 
      subsequent symptom-defined HFpEF during longitudinal follow-up. Model performance 
      was validated in a non-overlapping hold-out subset from all 22 UK Biobank 
      assessment centres (n = 100 446; 6726 HFpEF cases; 7394 with multi-omics data). 
      The classifier demonstrated robust discriminatory performance, with a receiver 
      operating characteristic area under the curve (ROC AUC) of 0.931 (95% confidence 
      interval [CI] 0.930-0.931), a sensitivity of 0.857 (95% CI 0.855-0.860) and a 
      specificity of 0.847 (95% CI 0.846-0.847). It identified individuals who 
      subsequently developed HFpEF an average of 6.3 ± 3.9 years before symptom onset 
      in asymptomatic individuals. Similarity network fusion (SNF) identified distinct 
      subgroups, including a high-risk cluster characterized by elevated mortality and 
      dysregulated inflammatory pathways, which was distinguishable with high accuracy 
      (ROC AUC 0.988; 95% CI 0.985-0.990). CONCLUSIONS: We identified HFpEF phenotypes 
      at an early stage, often several years before the onset of clinical symptoms, 
      when the disease trajectory may still be amenable to modification. The molecular 
      characterization provides novel insights into the underlying disease complexity 
      and enables more refined risk stratification.
CI  - © 2025 The Author(s). European Journal of Heart Failure published by John Wiley & 
      Sons Ltd on behalf of European Society of Cardiology.
FAU - Versnjak, Jakob
AU  - Versnjak J
AUID- ORCID: 0009-0009-6179-1014
AD  - Institute of Computer-assisted Cardiovascular Medicine, Deutsches Herzzentrum der 
      Charité, Berlin, Germany.
AD  - Charité-Universitätsmedizin Berlin, corporate member of Freie Universität Berlin 
      and Humboldt-Universität zu Berlin, Berlin, Germany.
FAU - Kuehne, Titus
AU  - Kuehne T
AUID- ORCID: 0000-0003-1631-4824
AD  - Institute of Computer-assisted Cardiovascular Medicine, Deutsches Herzzentrum der 
      Charité, Berlin, Germany.
AD  - Charité-Universitätsmedizin Berlin, corporate member of Freie Universität Berlin 
      and Humboldt-Universität zu Berlin, Berlin, Germany.
AD  - DZHK (German Centre for Cardiovascular Research), partner site Berlin, Berlin, 
      Germany.
AD  - Department of Congenital Heart Disease - Pediatric Cardiology, Deutsches 
      Herzzentrum der Charité, Berlin, Germany.
FAU - Fahjen, Pauline
AU  - Fahjen P
AUID- ORCID: 0000-0002-5015-0643
AD  - Proteomics Platform, Max-Delbrück-Center for Molecular Medicine, Berlin, Germany.
FAU - Jovanovic, Nina
AU  - Jovanovic N
AUID- ORCID: 0000-0001-6300-9705
AD  - Charité-Universitätsmedizin Berlin, corporate member of Freie Universität Berlin 
      and Humboldt-Universität zu Berlin, Berlin, Germany.
AD  - DZHK (German Centre for Cardiovascular Research), partner site Berlin, Berlin, 
      Germany.
AD  - Max Delbrück Center for Molecular Medicine in the Helmholtz Association, Berlin, 
      Germany.
AD  - Experimental and Clinical Research Center, a cooperation of 
      Charité-Universitätsmedizin Berlin and Max Delbrück Center for Molecular 
      Medicine, Berlin, Germany.
FAU - Löber, Ulrike
AU  - Löber U
AUID- ORCID: 0000-0001-7468-9531
AD  - Charité-Universitätsmedizin Berlin, corporate member of Freie Universität Berlin 
      and Humboldt-Universität zu Berlin, Berlin, Germany.
AD  - DZHK (German Centre for Cardiovascular Research), partner site Berlin, Berlin, 
      Germany.
AD  - Max Delbrück Center for Molecular Medicine in the Helmholtz Association, Berlin, 
      Germany.
AD  - Experimental and Clinical Research Center, a cooperation of 
      Charité-Universitätsmedizin Berlin and Max Delbrück Center for Molecular 
      Medicine, Berlin, Germany.
FAU - Schiattarella, Gabriele G
AU  - Schiattarella GG
AUID- ORCID: 0000-0002-7582-7171
AD  - Charité-Universitätsmedizin Berlin, corporate member of Freie Universität Berlin 
      and Humboldt-Universität zu Berlin, Berlin, Germany.
AD  - DZHK (German Centre for Cardiovascular Research), partner site Berlin, Berlin, 
      Germany.
AD  - Department of Cardiology, Angiology and Intensive Care Medicine, Deutsches 
      Herzzentrum der Charité (DHZC), Berlin, Germany.
AD  - Translational Approaches in Heart Failure and Cardiometabolic Disease, Max 
      Delbrück Center for Molecular Medicine in the Helmholtz Association (MDC), 
      Berlin, Germany.
FAU - Wilck, Nicola
AU  - Wilck N
AUID- ORCID: 0000-0003-3189-5364
AD  - Charité-Universitätsmedizin Berlin, corporate member of Freie Universität Berlin 
      and Humboldt-Universität zu Berlin, Berlin, Germany.
AD  - DZHK (German Centre for Cardiovascular Research), partner site Berlin, Berlin, 
      Germany.
AD  - Max Delbrück Center for Molecular Medicine in the Helmholtz Association, Berlin, 
      Germany.
AD  - Experimental and Clinical Research Center, a cooperation of 
      Charité-Universitätsmedizin Berlin and Max Delbrück Center for Molecular 
      Medicine, Berlin, Germany.
FAU - Gerhardt, Holger
AU  - Gerhardt H
AUID- ORCID: 0000-0002-3030-0384
AD  - Max Delbrück Center for Molecular Medicine in the Helmholtz Association, Berlin, 
      Germany.
FAU - Müller, Dominik N
AU  - Müller DN
AUID- ORCID: 0000-0003-3650-5644
AD  - Charité-Universitätsmedizin Berlin, corporate member of Freie Universität Berlin 
      and Humboldt-Universität zu Berlin, Berlin, Germany.
AD  - DZHK (German Centre for Cardiovascular Research), partner site Berlin, Berlin, 
      Germany.
AD  - Max Delbrück Center for Molecular Medicine in the Helmholtz Association, Berlin, 
      Germany.
AD  - Experimental and Clinical Research Center, a cooperation of 
      Charité-Universitätsmedizin Berlin and Max Delbrück Center for Molecular 
      Medicine, Berlin, Germany.
FAU - Edelmann, Frank
AU  - Edelmann F
AUID- ORCID: 0000-0003-4401-5936
AD  - Charité-Universitätsmedizin Berlin, corporate member of Freie Universität Berlin 
      and Humboldt-Universität zu Berlin, Berlin, Germany.
AD  - DZHK (German Centre for Cardiovascular Research), partner site Berlin, Berlin, 
      Germany.
AD  - Department of Cardiology, Angiology and Intensive Care Medicine, Deutsches 
      Herzzentrum der Charité (DHZC), Berlin, Germany.
FAU - Mertins, Philipp
AU  - Mertins P
AUID- ORCID: 0000-0002-2245-528X
AD  - Charité-Universitätsmedizin Berlin, corporate member of Freie Universität Berlin 
      and Humboldt-Universität zu Berlin, Berlin, Germany.
AD  - DZHK (German Centre for Cardiovascular Research), partner site Berlin, Berlin, 
      Germany.
AD  - Proteomics Platform, Max-Delbrück-Center for Molecular Medicine, Berlin, Germany.
FAU - Eils, Roland
AU  - Eils R
AUID- ORCID: 0000-0002-0034-4036
AD  - Berlin Institute of Health at Charité - Universitätsmedizin Berlin, Berlin, 
      Germany.
AD  - Health Data Science Unit, Heidelberg University Hospital and BioQuant, 
      Heidelberg, Germany.
FAU - Gotthardt, Michael
AU  - Gotthardt M
AUID- ORCID: 0000-0003-1788-3172
AD  - Charité-Universitätsmedizin Berlin, corporate member of Freie Universität Berlin 
      and Humboldt-Universität zu Berlin, Berlin, Germany.
AD  - DZHK (German Centre for Cardiovascular Research), partner site Berlin, Berlin, 
      Germany.
AD  - Department of Cardiology, Angiology and Intensive Care Medicine, Deutsches 
      Herzzentrum der Charité (DHZC), Berlin, Germany.
AD  - Translational Cardiology and Functional Genomics, Max Delbrück Center for 
      Molecular Medicine in the Helmholtz Association, Berlin, Germany.
FAU - Forslund, Sofia K
AU  - Forslund SK
AUID- ORCID: 0000-0003-4285-6993
AD  - Charité-Universitätsmedizin Berlin, corporate member of Freie Universität Berlin 
      and Humboldt-Universität zu Berlin, Berlin, Germany.
AD  - DZHK (German Centre for Cardiovascular Research), partner site Berlin, Berlin, 
      Germany.
AD  - Max Delbrück Center for Molecular Medicine in the Helmholtz Association, Berlin, 
      Germany.
AD  - Experimental and Clinical Research Center, a cooperation of 
      Charité-Universitätsmedizin Berlin and Max Delbrück Center for Molecular 
      Medicine, Berlin, Germany.
FAU - Wild, Benjamin
AU  - Wild B
AUID- ORCID: 0000-0002-7492-8448
AD  - Berlin Institute of Health at Charité - Universitätsmedizin Berlin, Berlin, 
      Germany.
AD  - Institute of Cardiovascular Sciences, University College London, London, UK.
FAU - Kelm, Marcus
AU  - Kelm M
AUID- ORCID: 0000-0003-4971-0452
AD  - Institute of Computer-assisted Cardiovascular Medicine, Deutsches Herzzentrum der 
      Charité, Berlin, Germany.
AD  - Charité-Universitätsmedizin Berlin, corporate member of Freie Universität Berlin 
      and Humboldt-Universität zu Berlin, Berlin, Germany.
AD  - DZHK (German Centre for Cardiovascular Research), partner site Berlin, Berlin, 
      Germany.
AD  - Department of Congenital Heart Disease - Pediatric Cardiology, Deutsches 
      Herzzentrum der Charité, Berlin, Germany.
LA  - eng
GR  - Deutsche Forschungsgemeinschaft: SFB-1470- A02,A03,A05,A06,A10,B04,B05,Z02,Z03/
GR  - 81X3100210,81X2100282,81Z0100106/Deutsches Zentrum für Herz-Kreislaufforschung/
GR  - 101078307/H2020 European Research Council/
GR  - 21CVD02/Foundation Leducq/
GR  - 01EJ2406A/Bundesministerium für Bildung und Forschung/
PT  - Journal Article
DEP - 20250922
PL  - England
TA  - Eur J Heart Fail
JT  - European journal of heart failure
JID - 100887595
SB  - IM
OTO - NOTNLM
OT  - AI, artificial intelligence
OT  - Explainable artificial intelligence
OT  - HFpEF, Heart failure with preserved ejection fraction
OT  - Heart Failure Stage A: At Risk for Heart Failure
OT  - Heart Failure Stage B: Pre‐Heart Failure
OT  - Machine learning
OT  - Multi‐omics
OT  - Pre‐symptomatic heart failure
EDAT- 2025/09/22 06:31
MHDA- 2025/09/22 06:31
CRDT- 2025/09/22 03:15
PHST- 2025/07/25 00:00 [revised]
PHST- 2025/05/06 00:00 [received]
PHST- 2025/08/13 00:00 [accepted]
PHST- 2025/09/22 06:31 [medline]
PHST- 2025/09/22 06:31 [pubmed]
PHST- 2025/09/22 03:15 [entrez]
AID - 10.1002/ejhf.70041 [doi]
PST - aheadofprint
SO  - Eur J Heart Fail. 2025 Sep 22. doi: 10.1002/ejhf.70041.
